National University of Medical Sciences (NUMS) and South Korean biopharmaceutical company Research and Development of Eyegene Inc have agreed in principle on setting up preventive vaccines production units in Pakistan on the basis of Public Private Partnership to further enhance cooperation between the two institutions.
This understanding was reached during a meeting of Vice Chancellor NUMS Lt Gen Wasim Alamgir HI(M) with Dr Seo-Hyun Kim,Head of R&D Center of Eyegene Inc and their teams, in South Korea, said a message received from Seoul here on Thursday.
The Vice-Chancellor also visited the R&D center and was given a detailed briefing by Professor Dr H. Christian Hong Chief Scientific Officer Renhain Therapeutics. He met scientists and researchers working on the development of mRNA and other vaccines at the center.
Both sides also identified other potential areas of collaboration including conduct of clinical trials for various therapeutic vaccines for the mutual benefit of the two countries, said the message.
Earlier NUMS also entered into collaboration with the South Korean International Vaccine Institute (IVI) and the School of Medicine Gachon University to collaborate in indigenous development of vaccines through transfer of technology and by building capacity of Pakistani scientists.
Lt Gen Wasim Alamgir during his visit to South Korea held separate meetings with Director General of International Vaccine Institute (IVI) South Korea Dr Jerome H. Kim and with Kee-Jong Hong PhD, Director General and Prof. School of Medicine of Gachon University, an understanding was reached for collaboration in this regard, said a message received here from Seoul on Thursday.
